Viewing Study NCT04466904


Ignite Creation Date: 2025-12-24 @ 9:12 PM
Ignite Modification Date: 2025-12-31 @ 2:10 AM
Study NCT ID: NCT04466904
Status: COMPLETED
Last Update Posted: 2021-07-23
First Post: 2020-07-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DM
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module